Altering Antigen Charge to Control Self-Assembly and Processing of Immune Signals During Cancer Vaccination

Biomaterial delivery systems offer unique potential to improve cancer vaccines by offering targeted delivery and modularity to address disease heterogeneity. Here, we develop a simple platform using a conserved human melanoma peptide antigen (Trp2) modified with cationic arginine residues that conde...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Shannon J., Amerman, Allie, Jewell, Christopher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815530/
https://www.ncbi.nlm.nih.gov/pubmed/33488621
http://dx.doi.org/10.3389/fimmu.2020.613830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815530/
https://www.ncbi.nlm.nih.gov/pubmed/33488621
http://dx.doi.org/10.3389/fimmu.2020.613830

Ejemplares similares